Registered entities
Dyne Therapeutics, Inc.
Reg. No. 1818794United States
DYNE THERAPEUTICS INC
Reg. No. 364883909United States
Innovation
81 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport; filing pace steady. Cited 31,570 times.
| Year | Filings |
|---|---|
| 2020 | 11 |
| 2021 | 25 |
| 2022 | 32 |
| 2023 | 48 |
| 2024 | 48 |
| 2025 | 40 |
| 2026 | 5 |
Social engagement
Social engagement: 28.9K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
7 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 43% |
| Bank & private debt | 1 | 14% |
| Other / undisclosed | 3 | 43% |
Hiring activity
Hires frequently
14 roles tracked across 6 of the last 12 months
10 Jun 2026 · Executive Director, Regulatory Affairs Advertising & Promotion · Waltham
10 Jun 2026 · Medical Director, US Medical Affairs · Waltham
4 Apr 2026 · Senior Manager, Scientific and Medical Education · Waltham
22 Jan 2026 · VP, Customer Experience · Joint Base Lewis-McChord
19 Jan 2026 · Director, Compliance · Waltham
Based on job postings tracked across public sources.
Recent activity
1 Jul 2026
Event
Parent Project Muscular Dystrophy Annual Conference
26 Jun 2026
Event
FSHD Connect Conference
25 Jun 2026
Event
Parent Project Muscular Dystrophy Annual Conference